Furui Co.,Ltd(300049) 光大证券·2025-05-05 15:10Investment Rating - The report maintains a rating of "Accumulate" for the company [6]. Core Insights - The company achieved a revenue of 1.349 billion yuan in 2024, representing a year-over-year growth of 16.93%, and a net profit attributable to the parent company of 113 million yuan, up 11.54% year-over-year [2]. - In Q1 2025, the company reported a revenue of 330 million yuan, a slight increase of 2.35% year-over-year, but the net profit attributable to the parent company decreased by 32.97% to 29 million yuan, falling short of previous expectations [2][4]. - The pharmaceutical segment saw significant growth, with revenues reaching 382 million yuan in 2024, a 34.2% increase year-over-year, driven by substantial growth in both commercial sales channels and e-commerce platforms [3]. - The medical device segment also showed steady growth, with revenues of 923 million yuan in 2024, a 10.98% increase year-over-year, supported by a growing pay-per-use model [3]. Summary by Sections Financial Performance - In 2024, the company reported total revenue of 1.349 billion yuan, with a net profit of 113 million yuan. The Q1 2025 results showed revenue of 330 million yuan and a net profit of 29 million yuan [2][4]. - The pharmaceutical segment's revenue was 382 million yuan in 2024, with a gross margin improvement of 9.46 percentage points to 47.7% [3]. - The medical device segment generated 923 million yuan in revenue, with a notable 25.23% increase in pay-per-use and leasing income [3]. Profitability Forecast - The net profit forecasts for 2025 and 2026 have been revised down to 179 million yuan and 253 million yuan, respectively, reflecting a decrease of 44.2% and 44.6% from previous estimates [4]. - The company is projected to achieve a net profit of 328 million yuan by 2027, with corresponding price-to-earnings ratios of 45, 32, and 24 for 2025, 2026, and 2027, respectively [4]. Market Position - The company is recognized as a leader in non-invasive screening for MASH, with its products distributed across major countries in Europe, Asia, and North America [4].